Biotech entity
pharma is the sole category represented across all 2 tracked stories. Namit Joshi is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.
Last mentioned: Aug 1, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. Namit Joshi is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. At 6, the average consequence score sits above the same-window beat average of 5.9. This profile follows 2 Biotech stories mentioning Pharmexcil across the period from July 27, 2026 to August 1, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 50 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pharmexcil. Shared-story counts are live from our verified record — not editorial picks.
The proposed US tariff on generic drugs—jumping to 200%—poses an existential threat to Indian pharmaceutical companies that have long dominated the American market. With margins razor-thin and a 4-5 year timeline needed to onshore production, industry leaders call the plan 'completely out of scope,' potentially forcing a major restructuring of global generic supply chains.
Source: heraldglobe.com · milwaukeesun.com
The zero-tariff India-UK trade pact propels Indian pharmaceutical exports to a projected $981M, offering biotech and pharma firms expanded market access, lower costs, and new collaboration channels in R&D and manufacturing.
Source: indiagazette.com · britainnews.net
Pharmexcil is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
